XML 113 R86.htm IDEA: XBRL DOCUMENT
v3.21.1

Investments in Associate (Disclosure of Associates) (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2020 | Dec. 31, 2019
Disclosure of associates [line items] |  |
Shares and warrants presented as marketable securities at beginning | $ 1,331 | $ 4,277
Write down of investment |  | (2,721)
Share of net income (loss) | (76) | (225)
Transfer to investments in equity securities | (1,255) |
Shares and warrants presented as marketable securities at ending |  | 1,331
Medgold |  |
Disclosure of associates [line items] |  |
Shares and warrants presented as marketable securities at beginning | 974 | 3,075
Write down of investment |  | (1,937)
Share of net income (loss) | (47) | (164)
Transfer to investments in equity securities | (927) |
Shares and warrants presented as marketable securities at ending |  | 974
Prospero |  |
Disclosure of associates [line items] |  |
Shares and warrants presented as marketable securities at beginning | 357 | 1,202
Write down of investment |  | (784)
Share of net income (loss) | (29) | (61)
Transfer to investments in equity securities | $ (328) |
Shares and warrants presented as marketable securities at ending |  | $ 357

X
- Definition Reconciliation of equity method investment transfer to equity securities. + References No definition available. + Details
Name: | fsm_ReconciliationOfEquityMethodInvestmentTransferToEquitySecurities
Namespace Prefix: | fsm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value of investments in associates if there are quoted market prices for the investment. [Refer: Associates [member]; Investments in associates] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2020-01-01 -Paragraph 21 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_21_b_iii&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2021-01-01 -Name IFRS -Number 7 -IssueDate 2020-01-01 -Paragraph 20 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b -URIDate 2020-01-01 + Details
Name: | ifrs-full_ImpairmentLossOnFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) from continuing operations of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Continuing operations [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss) from continuing operations] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2020-01-01 -Paragraph B16 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B16_a&doctype=Appendix&subtype=B -URIDate 2020-01-01 + Details
Name: | ifrs-full_ShareOfProfitLossOfContinuingOperationsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=fsm_MedgoldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=fsm_ProsperoSilverCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |